Skip to main content
. 2009;120:177–187.

Fig. 2.

Fig. 2

Changes in weight and filling pressure during the weeks prior to a “hypervolemic” heart failure event for 163 adjudicated events in 90 patients in the COMPASS trial including ambulatory hemodynamic monitoring. The daily weight did not increase detectably, whereas there was a rise in diastolic filling pressure beginning over 3 weeks prior to the event, and decreasing sharply during therapy for the event.